Cardiovascular disease in chinese women: An emerging high-risk population and implications for nursing practice

Journal of Cardiovascular Nursing

Volumn 23, Issue 5, 2008, Pages 386-394

  Cao, Yingjuan ^a,b   Digiacomo, Michelle ^c   Du, Hui Yun ^c   Ollerton, Eirwyn ^d   Davidson, Patricia ^a,c  

^a CURTIN UNIVERSITY   (Australia)

^b Centre for Health Services Management   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Cardiovascular disease; Risk factors; Women

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHINA; COST OF ILLNESS; DYSLIPIDEMIA; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LIFE EXPECTANCY; LIFESTYLE; MALE; MIDDLE AGED; NURSING; PREVALENCE; RISK FACTOR; SEX RATIO; SMOKING; SOCIAL CHANGE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHINA; COST OF ILLNESS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LIFE EXPECTANCY; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SOCIAL CHANGE;

EID: 56049091774     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/01.JCN.0000317446.97951.c2     Document Type: Article

References (69)

1. Mikhail GW. Coronary heart disease in women. BMJ. 2005;331(7515):467-468.
2. World Health Organization. WHO publishes results of largest-ever global collaboration on heart disease. WHO news release. www.who.int/mediacentre/news/ releases/ 2003/pr72/en/. Accessed September 26, 2003.
3. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353(11): 1124-1134.
4. People's Republic of China Ministry of Health, Annual Report on Health 2006. www.moh.gov.cn. Accessed February 2007.
5. The 2000 Victoria Declaration on Women, Heart Disease and Stroke. Board of the First International Conference on Women, Heart Disease and Stroke; May 8-10, 2000; Victoria, Canada. http://www.cwhn.ca/resources/victoria-declaration/ victoria.pdf. Accessed July 1, 2006.
6. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109(5):672-693.
7. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97(6): 596Y601.
8. Magazine TH. Heart disease strikes China. www.heartzine. com. Accessed December 9, 2004.
9. World Bank. World Bank Annual Report 2001. http:// www- wds.worldbank.org/external/default/main? pagePK=64193027&piPK= 64187937&theSitePK= 523679&menuPK=64187510&searchMenuPK= 64187283&theSitePK=523679&entityID=000094946- 02122004122025&searchMenuPK=64187283&theSitePK= 523679. Accessed July 1, 2006.
10. World Bank. Key Development Data & Statistics-China Data Profile. http://ddp-ext.worldbank.org/ext/ddpreports/ ViewSharedReport?&CF= 1&REPORT-ID=9147& REQUEST-TYPE=VIEWADVANCED&HF=N&WSP=N, World Development Indicators Database. Accessed July 1, 2006.
11. Leeder S, Raymond S, Greenberg H, et al. A race against time: the challenge of cardiovascular disease in the developing world. New York, NY: Columbia University Earth Institute. www.earth.columbia.edu. Accessed October 18, 2005.
12. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6): 2404-2411.
13. Ministry of Public Health, PRC. Health statistics information in China, 1949-1988. Beijing, China: Ministry of Public Health; 1990.
14. Wu Z, Yao C, Zhao D, et al. Cardiovascular disease risk factor levels and their relations to CVD rates in China-results of Sino-MONICA project. Eur J Cardiovasc Prev Rehabil. 2004;11(4):275-283.
15. Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians of European, South Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ. 1999; 161(2):132-138.
16. Harland JO, Unwin N, Bhopal RS, et al. Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Comm Health. 1997;51(6):636-642.
17. Gu D, Gupta A, Muntner P, et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation. 2005;112(5):658-665.
18. NHANES. 1999-2000 Addendum to the NHANES III analytic guidelines. www.cdc.gov/nchs/data/nhanes/guidelines1. pdf. Accessed January 9, 2004.
19. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983-1992.
20. Fang XH, Longstreth WT Jr, Li SC, et al. Longitudinal study of blood pressure and stroke in over 37,000 People in China. Cerebrovasc Dis. 2001;11(3):225-229.
21. Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension. 2002;40(6):920-927.
22. Tang JL, Hu YH. Drugs for preventing cardiovascular disease in China. BMJ. 2005;330(7492):610-611.
23. American Heart Association, China (CVD Statistics Fact Sheet). www.americanheart.org/presenter.jhtml?identifier= 2572. Accessed March 8, 2005.
24. Wang Z, Wu Y, Zhao L, et al. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertens Res Clin Exp. 2004;27(10):703-709.
25. Antikainen RL, Moltchanov VA, Chukwuma C Sr, et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil. 2006;13(1):13-29.
26. Trynosky KJ. Missed targets: gender differences in the identification and management of dyslipidemia. J Cardiovasc Nurs. 2006;21(5):342-346.
27. American Heart Association. Heart Disease and Stroke Statistics -2005 Update. Dallas, TX: American Heart Association; 2005.
28. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003;107(17): 2185-2189.
29. Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004;110(10): 1236-1244.
30. He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation. 2004; 110(4):405-411.
31. Mosca L, Grundy SM, Judelson D, et al. Guide to preventive cardiology for women. AHA/ACC scientific statement consensus panel statement. Circulation. 1999; 99(18):2480-2484.
32. American Heart Association. Women, heart disease and stroke. www.americanheart.org/presenter.jhtml?identifier= 4786. Accessed March 14, 2007.
33. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation. 1997; 96(7):2468-2482.
34. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5): 1047-1053.
35. Bernhard D, Csordas A, Henderson B, Rossmann A, Kind M, Wick G. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by de-polymerization of microtubules. FASEB J. 2005;19(9): 1096-1107.
36. Liu T, Xiong B. Tobacco Economy and Tobacco Control (in Chinese). Beijing, China: Economic Science Press; 2004.
37. Petersen S, Peto V, Rayner M. Coronary Heart Disease Statistics 2004. London: British Heart Foundation. http:// www.heartstats.org/datapage.asp?id= 1652. Accessed March 8, 2005.
38. Yang G, Fan L, Tan J, et al. Smoking in China: findings of the 1996 National Prevalence Survey. JAMA. 1999; 282(13):1247-1253.
39. Enstrom JE, Kabat GC. Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians. 1960-98. BMJ. 2003;326(7398):1057.
40. Zhang X, Shu XO, Yang G, et al. Association of passive smoking by husbands with prevalence of stroke among Chinese women nonsmokers. Am J Epidemiol. 2005; 161(3):213-218.
41. Wen W, Shu XO, Gao YT, et al. Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study. BMJ. 2006; 333(7564):376.
42. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. Canadian Medical Association Journal. 2006;174(6):801-809.
43. Jing Ma ZL, Wenhua L. Physical activity, diet and cardiovascular disease risks in Chinese women. Public Health Nutrition. 2002;6(2):139-146.
44. Muntner P, Gu D, Wildman RP, et al. Prevalence of physical activity among Chinese adults: results from the International Collaborative Study of Cardiovascular Disease in Asia. Am J Public Health. 2005;95(9): 1631-1636.
45. Wu Y. Overweight and obesity in China. BMJ. 2006; 333(7564):362-363.
46. American Heart Association. China CVD statistics. 2001. www.essentialdrugs.org/newsview.php/63. Accessed January 19, 2005.
47. Li G, Chen X, Jang Y, et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes Rev. 2002;3(3):167-172.
48. Wildman RP, Gu D, Reynolds K, Duan X, He J. Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr. 2004; 80(5):1129-1136.
49. Zhou GL, Liu XF, Xu GL, Liu XF, Zhang RL, Zhu WS. The effect of socioeconomic status on three-year mortality after first-ever ischemic stroke in Nanjing, China. BMC Public Health. 2006;6:227.
50. Yu Z, Nissinen A, Vartiainen E, et al. Associations between socioeconomic status and cardiovascular risk factors in an urban population in China. Bull WHO. 2000;78(11):1296-1305.
51. Yu Z, Nissinen A, Vartiainen E, Song G, Guo Z, Tian H. Changes in cardiovascular risk factors in different socio-economic groups: seven year trends in a Chinese urban population. J Epidemiol Community Health. 2000;54(9): 692-696.
52. Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA. 2005;294(24): 3117-3123.
53. Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291(18): 2204-2211.
54. Mendis S. Cardiovascular risk assessment and management in developing countries. Vasc Health Risk Manag. 2005;1(1):15-18.
55. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9437):937- 952.
56. Albert NM. We are what we eat: women and diet for cardiovascular health. J Cardiovasc Nurs. 2005;20(6):451-460.
57. Yang G, Shu XO, Jin F, et al. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr. 2005;81(5): 1012-1017.
58. Li WW, Stewart AL, Stotts N, Froelicher ES. Cultural factors associated with antihypertensive medication adherence in Chinese immigrants. J Cardiovasc Nurs. 2006;21(5):354-362.
59. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104(13):1577-1579.
60. Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104(4):499-503.
61. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106(3):388-391.
62. Davidson P, Hancock K, Leung D, et al. Traditional Chinese medicine and heart disease: what does Western medicine and nursing science know about it? Eur J Cardiovasc Nurs. 2003;2(3):171-181.
63. Chen Wenli C, Huang T, Zhenshan Y, et al. Evaluation of community intervention on cardiovascular disease in Guzhen town, Zhongshan City, Guangdong Province. Chin J Clin Rehabil. 2005;9(37):124-126.
64. Wang WZ, Yang WS, Hong Z, et al. The change of mortality of stroke after a community-based intervention trial for nine years in three cities of China. Chin J Prev Contr Chron Noncommun Dis. 2002;10(2):49-51.
65. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic diseases in China. Lancet. 2005;366(9499): 1821-1824.
66. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366(9496):1578-1582.
67. Ko GT, Li JK, Kan EC, Lo MK. Effects of a structured health education programme by a diabetic education nurse on cardiovascular risk factors in Chinese type 2 diabetic patients: a 1-year prospective randomized study. Diabet Med. 2004;21(12):1274-1279.
68. Elsaesser A, Hamm CW. Acute coronary syndrome: the risk of being female. Circulation. 2004;109(5):565-567.
69. Cheek DR, Jensen L, Smith H. Preventing and treating: heart disease in women. Nursing. 2004;34:4-8.